Hydroxychloroquine
FDA Approved
Description
Hydroxychloroquine is an antimalarial drug that is also used to treat autoimmune diseases, including chronic cutaneous lupus erythematosus. It helps to reduce inflammation and pain associated with the condition.
Indications & Therapeutic Use
Chronic Cutaneous Lupus Erythematosus
Linked Diseases:
Global Availability (4 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
Hydroxychloroquine
| Generic Name | Hydroxychloroquine |
| Brands | 1 brand available |
| Active Ingredient | Hydroxychloroquine sulfate |
| Drug Class | Chronic Cutaneous Lupus Erythematosus |
| Manufacturer | Sanofi-Aventis |
| Dosage Forms | Tablet |
| Medical Code | P01BA02 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 7 days |
| Reg. Status | FDA Approved |
| Countries | 4 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations5 Validated Nodes